Suchergebnisse - "Tan, Yijiong"

PubPharm (4)

1

Effectiveness and safety of once-weekly subcutaneous semaglutide versus other glucose-lowering agents in real-world patients with type 2 diabetes : A retrospective, observational post-marketing study

enthalten in: Diabetes, obesity & metabolism | 2024

von Shi, C. | Tan, Y. | Hu, S. | +4

2

The risk factors of diabetic ketosis and diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors : a retrospective study

enthalten in: Expert opinion on drug safety | 2024

von Zhao, Q. | Tan, Y. | Wu, Q. | +7

3

Interrelation between the lipid accumulation product index and diabetic kidney disease in patients with type 2 diabetes mellitus

enthalten in: Frontiers in endocrinology | 2023

von Tang, M. | Yao, S. | Cao, H. | +7

4

Association between use of liraglutide and liver fibrosis in patients with type 2 diabetes

enthalten in: Frontiers in endocrinology | 2022

von Tan, Y. | Zhen, Q. | Ding, X. | +8

1
[1]